Rob Bailey

Robert Bailey serves as a primary procurement lead for the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, where he manages complex research and technical acquisitions aligned with NIDA’s mission to advance scientific understanding of substance use disorders. He oversees the solicitation and award of contracts supporting cutting-edge neurobiological, behavioral, and clinical research initiatives, with a focus on laboratory instrumentation, data analysis systems, and translational science services. His procurement activities bridge scientific innovation and operational execution, ensuring that research infrastructure meets rigorous federal standards while enabling high-impact public health outcomes. Bailey maintains longstanding relationships with leading academic and research institutions, including The McLean Hospital Corporation, the University of Maryland, Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a preference for mission-aligned, high-capacity research entities capable of delivering sophisticated scientific services, from neuroimaging analytics to clinical trial support. His contracting patterns emphasize long-term, performance-based agreements that foster sustained collaboration between federal science objectives and institutional research capabilities. While the majority of NIDA’s procurements under his purview are unrestricted (71.8%), Bailey consistently prioritizes small business participation, with nearly one-quarter of awards designated as total small business set-asides under FAR 19.5. He also supports 8(a) competed contracts, demonstrating a deliberate effort to expand opportunities for socioeconomically disadvantaged firms within the scientific services sector, aligning with federal socioeconomic goals while maintaining technical rigor. His procurement focus centers on NAICS 334516 (analytical laboratory instrument manufacturing) and 811210 (electronic and precision equipment repair), reflecting a strong demand for specialized research hardware and maintenance services. He also procures research and development services under NAICS 541715 and testing laboratory services under 541380, underscoring expertise in life sciences infrastructure, data acquisition systems, and analytical instrumentation critical to addiction research.